Structured evidence table for Folate Blood Pressure Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Folate Blood Pressure Meta-Analysis | Epidemiological evidence highlights both the high prevalence and serious consequences of these disorders. | 3 | Zhang Tingyin (2026) | Multigene Screening of B-Vitamin Metabolism Pathways in Hypertensive Disorders of Pregnancy: Toward Precision Prenatal Care |
| Folate Blood Pressure Meta-Analysis | For instance, a large national cohort study in China involving more than two million pregnant women reported that ambient environmental factors, such as temperature fluctuations, can influence the incidence of preeclampsia and gestational hypertension, underscoring the multifactorial nature of HDP.The global burden of HDP is also reflected in its associated maternal and perinatal morbidity and mortality. | 3 | Zhang Tingyin (2026) | Multigene Screening of B-Vitamin Metabolism Pathways in Hypertensive Disorders of Pregnancy: Toward Precision Prenatal Care |
| Folate Blood Pressure Meta-Analysis | Affected women have increased risks of cardiovascular and cerebrovascular diseases, cognitive decline, and other neurological disorders later in life.Collectively, these findings highlight the critical need for early diagnosis, careful risk stratification, and effective management strategies to reduce both immediate and long-term adverse outcomes associated with HDP. | 3 | Zhang Tingyin (2026) | Multigene Screening of B-Vitamin Metabolism Pathways in Hypertensive Disorders of Pregnancy: Toward Precision Prenatal Care |
| Folate Blood Pressure Meta-Analysis | 1 2 3 4 5–7 HDP remain a major clinical challenge worldwide, posing substantial risks to both maternal and fetal well-being. | 3 | Zhang Tingyin (2026) | Multigene Screening of B-Vitamin Metabolism Pathways in Hypertensive Disorders of Pregnancy: Toward Precision Prenatal Care |
| Folate Blood Pressure Meta-Analysis | 3 3 4 4 5 7 8 11 Metabolic diseases, an array of disorders including type 2 diabetes (T2D) and obesity, and risk factors such as hypertension and hyperlipidaemia have also been increasing globally []. | 3 | Yoo Samantha (2026) | Folate and global health review series, part 3: syntheses on cardiovascular, cerebrovascular, and metabolic diseases |
| Folate Blood Pressure Meta-Analysis | Metabolic disorders often occur concurrently and are risk factors associated with CVDs [–], with associations between metabolic syndrome and cardiovascular morbidity and mortality being well-documented [–]. | 3 | Yoo Samantha (2026) | Folate and global health review series, part 3: syntheses on cardiovascular, cerebrovascular, and metabolic diseases |
| Folate Blood Pressure Meta-Analysis | More specifically, the blood concentration of homocysteine is a well-established risk factor for vascular damage and atherosclerosis, and can be lowered with higher intakes of folate [–]. | 3 | Yoo Samantha (2026) | Folate and global health review series, part 3: syntheses on cardiovascular, cerebrovascular, and metabolic diseases |
| Folate Blood Pressure Meta-Analysis | 1 2 Cardiovascular diseases (CVDs) encompass multiple subcategories of conditions, including coronary artery disease (CAD), heart failure, cerebrovascular diseases, cardiomyopathy, and peripheral artery disease. | 3 | Yoo Samantha (2026) | Folate and global health review series, part 3: syntheses on cardiovascular, cerebrovascular, and metabolic diseases |
Source documents